Copiloting Predictability with AI and ML to Beat the Second Hit in Colorectal, Breast and Lung Cancers
CSEF · 2026 Computational Science (Senior Division)
Overview
The most common lethal forms of cancers like colorectal, lung, and breast cancers will need early detection through precise molecular characterization, forsensitivity or specificity needed for optimal patient care. I used large-scale, real-world patient data to investigate epigenetic changes distinguishing normal from cancerous tissue and progression. I focused on three key tumor-suppressor genes: TP53 (many cancers), BRCA1 (breast cancer), and APC (colorectal cancer). Genomic and epigenomic datasets from The Cancer Genome Atlas (TCGA), were accessed through Genomic Data Commons (GDC), with colorectal, lung, and breast tissues. I studied ALU and LINE-1 (L1) elements, which are suppressed by DNA methylation levels, in and around TP53, BRCA1, and APC across samples and at different cancer stages. Lower DNA methylation values occurred much more frequently in cancerous samples, suggesting increased potential for genomic instability, fluctuating across progressing stages, as possible dynamic biomarkers. I developed three supervised machine learning models. First one classified normal versus cancerous tissue with high accuracy, with AUC values of 1.00 for colorectal (COAD), 1.00 for lung cancer (LUAD), and 0.93 for breast cancer (BRCA). Second one identified high-risk tumors, achieving AUC values between 0.81-0.86. Third one, identified possible cancer type (breast, colon, or lung) and if the sample was tumor or normal, with an overall accuracy of about 80%. Integrating cancer genomics with epigenetic analysis, machine learning can powerfully diagnose, identify cancer type, and reflect disease progression in colorectal, lung, and breast cancers. With further refinement, models could support community by earlier detection for better treatment planning.
Competition history
- CSEF 2026
Related projects
ISEF · 2020
A Matter of Life and Breath: Early Lung Cancer Detection via Deep Learning CT Scan Analysis and DNA Methylation/exRNA Sequencing
ISEF · 2020
PANCREAS.AI: Novel Deep Learning-based Screening Towards Precision Applications for Pancreatic Cancer
ISEF · 2022
Novel Prediction of Five-Year Survival and Recurrence Rates and Discovery of Cancer Genetic Biomarkers Using MIBI Scans in the Tumor-Immune Microenvironment
CSEF · 2019
Integrating Mathematical Modeling with Machine Learning for Cancer Driver Gene Identification
ISEF · 2022
A Quantum Machine Learning-Based Framework for Early Cancer Detection and Biomarker Identification Through Transcriptome Profiles
ISEF · 2019
Classifying Cancer Using Machine Learning in Order for CRISPR/Cas9 Technology to Be More Effective
ISEF · 2021
Combined Artificial Intelligence and Nano-cell Internalization to Predict Cancer Aggressiveness
CSEF · 2018
iDetect: A Machine Learning Algorithm for Non-Invasive Cancer Diagnosis through Epigenetic Biomarker Identification
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects